Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Abbott Laboratories Biotech Facility, Puerto Rico

Order Year

2002

Project Type

Biologics facility

Output Chemicals

Humira (adalimumab) (CAT-derived human anti-TNFa [tumour necrosis factor a]) monoclonal antibody

Location

Barceloneta, Commonwealth of Puerto Rico

Estimated Investment

$450m (£336m)

Construction Started

2003

Completion

2005 (then validation took until April 2007)

Sponsors

Abbott Laboratories, Abbott Biotechnology Ltd

General Contractor

Insulation Specialties, Pharmabio, Cives Steel Company Corp, Industrial Sprinklers

Engineering

LG Scott

Financing

Abbott Laboratories and tax incentives from the Government of the Commonwealth of Puerto Rico
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top